Output details

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

Justification Statement(a): the author made a substantial contribution either to

(i) the conception and design of the study;

(ii) to the organisation and conduct of the study;

(iii) to carrying out the study (including acquisition of study data;

(iv) to analysis and interpretation of study data);

and

(b): The author helped

(i) draft the output

(ii) critiqued the output for important intellectual content.